Booth Andrew 4
4 · AbCellera Biologics Inc. · Filed Dec 9, 2021
Insider Transaction Report
Form 4
Booth Andrew
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2021-12-07+406,020→ 5,884,820 totalExercise: $14.55Exp: 2031-12-07→ Common Shares (406,020 underlying)
Holdings
- 130,959(indirect: By Spouse)
Common Shares
- 53,500
Common Shares
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date